| |
| |
|
| Insider
Information: |
Avelar Rui |
| Relationship: |
See Remarks |
| City: |
Vancouver |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
377,888 |
|
|
Indirect Shares
|
3,684 |
|
|
| Direct
Value |
$4,996,105 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
381,572 |
|
|
| Total
Value |
$4,996,105 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -5.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Angiotech Pharmaceuticals Inc(USA) |
ANPIQ |
Officer |
2008-03-31 |
5,600 |
2008-03-31 |
3,684 |
Premium* |
|
|
Evolus Inc |
EOLS |
See Remarks |
2024-03-19 |
372,288 |
2019-12-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2024-03-19 |
4 |
S |
$13.92 |
$384,350 |
D/D |
(27,603) |
372,288 |
0 |
% |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2024-02-22 |
4 |
AS |
$13.08 |
$23,821 |
D/D |
(1,821) |
399,891 |
0 |
% |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2024-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
13,115 |
401,712 |
0 |
- |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
35,211 |
388,597 |
0 |
- |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2023-08-16 |
4 |
AS |
$10.27 |
$22,707 |
D/D |
(2,211) |
353,386 |
0 |
% |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2023-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
19,672 |
355,597 |
0 |
- |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2023-03-14 |
4 |
AS |
$8.47 |
$126,237 |
D/D |
(14,906) |
335,925 |
0 |
% |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
97,642 |
350,831 |
0 |
- |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2022-03-08 |
4 |
AS |
$9.73 |
$99,121 |
D/D |
(10,192) |
253,189 |
0 |
% |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
53,571 |
263,381 |
0 |
- |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2021-08-10 |
4 |
AS |
$11.18 |
$159,789 |
D/D |
(14,293) |
209,810 |
0 |
% |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2021-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
224,103 |
0 |
- |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2021-01-25 |
4 |
AS |
$7.46 |
$20,135 |
D/D |
(2,699) |
134,103 |
0 |
% |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2020-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
136,802 |
0 |
- |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2020-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
96,802 |
0 |
- |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2020-01-07 |
4 |
AS |
$10.71 |
$422,282 |
D/D |
(39,442) |
70,802 |
0 |
% |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2019-12-10 |
4 |
OE |
$9.98 |
$100,000 |
D/D |
10,020 |
110,244 |
0 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
Chief Medical OfficerOfficer |
• – – |
2008-03-31 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
5,600 |
|
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
Chief Medical OfficerOfficer |
• – – |
2008-03-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,684 |
|
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
Chief Medical OfficerOfficer |
• – – |
2008-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
516 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
